2.5 mg semaglutide / Cyanocobalamin Injection Semaglutide 2.5mg - 4 injections

Phase 2 trial in type 2 diabetes (Lancet 2023) also showed superior weight loss for the combination versus either monotherapy

Semaglutide activates GLP-1 receptors in your brain and gut to regulate appetite and blood sugar, but this mechanism can trigger nausea as your body adapts

Common side effects include: Nausea, especially in the early weeks Occasional vomiting or diarrhea Fatigue or mild headaches Redness or discomfort at the injection site Less common but more serious risks include: Pancreatitis Gallbladder issues Kidney concerns in patients with pre-existing conditions The key to safe treatment is proactive monitoring

PlexusDx supports precision-wellness through biomarker assessment and genetic context before treatment initiation